FDA Adverse Event Injury Summary report: N

INCEPTA

MDR report key: 3211651 · Received July 8, 2013

Report

Report Number
2124215-2013-08230
Event Type
Injury
Date Received
July 8, 2013
Date of Event
May 7, 2013
Report Date
May 20, 2013
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

BOSTON SCIENTIFIC RECEIVED ADDITIONAL INFORMATION. THIS DEVICE AND THE CHRONIC LEADS WERE LATER EXPLANTED DUE TO THE EROSION, AND A NEW, COMPETITIVE DEVICE AND LEAD SYSTEM WERE IMPLANTED ON THE PATIENT'S OTHER SIDE. NO RETURN OF EXPLANTED PRODUCTS IS EXPECTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED. AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Additional Manufacturer Narrative · 1

A REQUEST WAS MADE TO OBTAIN ADDITIONAL INFORMATION; HOWEVER, NO ADDITIONAL INFORMATION HAS BEEN RECEIVED. THE STATUS OF THE DEVICE IS NOT KNOWN. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PATIENT IMPLANTED WITH THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) PRESENTED TO A HOSPITAL BECAUSE THE DEVICE WAS EXPOSED THROUGH THE PATIENT'S SKIN. THE PHYSICIAN BELIEVED EITHER AN INFECTION OR ALLERGIC REACTION CAUSED THE EROSION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
310928 INCEPTA IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND F163

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| L| R